Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
American Heart Journal|May 29, 2000
New insights in cardiac structural changes in patients with Fabry's diseaseA Linhart, T Palecek, J Bultas, et al.
Bratislavske Lekarske Listy|July 5, 2013
Prediction of coronary vessel involvement on the basis of atherosclerosis risk factor analysisT Kovarnik, A Kral, H Skalicka, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|September 17, 2016
Injuries in Adults 65 Years of Age and Older Prescribed Muscle RelaxantsMelissa M Derner, Courtney A Linhart, LeeAnna M Pederson, et al.
Folia Biologica|February 13, 2017
Cystatin C Is Associated with the Extent and Characteristics of Coronary Atherosclerosis in Patients with Preserved Renal FunctionA Král, T Kovárník, Z Vaníčková, et al.
Glycobiology|June 18, 2021
Evidence for nutrient-dependent regulation of the COPII coat by O-GlcNAcylationBrittany J Bisnett, Brett M Condon, Noah A Linhart, et al.
European Journal of Clinical Investigation|December 21, 2004
Fabry disease: overall effects of agalsidase alfa treatmentM Beck, R Ricci, U Widmer, et al.
Folia Biologica|November 30, 2011
Genetic variants in haem oxygenase-1 and endothelial nitric oxide synthase influence the extent and evolution of coronary artery atherosclerosisA Král, T Kovárník, L Králík, et al.
Casopis Lekaru Ceskych|April 28, 2006
[Pulmonary endarterectomy--the surgical treatment of chronic thromboembolic pulmonary hypertension]J Lindner, P Jansa, J Kunstýr, et al.
The Journal of Cardiovascular Surgery|May 18, 2011
A review of a newly established ECMO program in a university affiliated cardiac centerJ Belohlávek, V Rohn, J Tosovsky, et al.
Molecular Genetics and Metabolism|March 1, 2021
Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensusD Moreno-Martinez, P Aguiar, C Auray-Blais, et al.
Pageof 11